Prevention of venous thromboembolism.

PubWeight™: 5.59‹?› | Rank: Top 1%

🔗 View Article (PMID 11157647)

Published in Chest on January 01, 2001

Authors

W H Geerts1, J A Heit, G P Clagett, G F Pineo, C W Colwell, F A Anderson, H B Wheeler

Author Affiliations

1: Thromboembolism Program, Sunnybrook & Women's College Health Sciences Centre, Toronto, ON, Canada.

Articles citing this

(truncated to the top 100)

Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ (2003) 3.73

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ (2006) 3.58

Pulmonary embolism in hospital practice. BMJ (2006) 2.27

Venous thromboprophylaxis in UK medical inpatients. J R Soc Med (2005) 2.14

Cellular basis for age-related changes in fracture repair. J Orthop Res (2005) 1.99

Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients: a systematic review. World J Surg (2015) 1.44

Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol (2004) 1.44

High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer (2007) 1.42

Does regional anesthesia improve outcome after total knee arthroplasty? Clin Orthop Relat Res (2009) 1.34

Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors. Clin Orthop Relat Res (2013) 1.25

Venous thromboembolic disease and cancer. Postgrad Med J (2006) 1.23

Inflammation and the host response to injury a large-scale collaborative project: patient-oriented research core standard operating procedure for clinical care X. Guidelines for venous thromboembolism prophylaxis in the trauma patient. J Trauma (2008) 1.20

Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15

Incidence and management of pulmonary embolism following spinal surgery occurring while under chemical thromboprophylaxis. Eur Spine J (2008) 1.12

Prevention of venous thromboembolism in spinal surgery. Eur Spine J (2003) 1.12

Prophylaxis in elective colorectal surgery: the cost of ignoring the evidence. Can J Surg (2003) 1.10

Deep vein thrombosis after total hip and knee arthroplasty in Indian patients. Postgrad Med J (2004) 1.10

Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. Br J Cancer (2008) 1.08

Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ (2008) 1.07

Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop (2007) 1.03

Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward. World J Surg (2006) 1.01

Thromboprophylaxis in spinal surgery: a survey. J Orthop Surg Res (2012) 0.99

A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients. Thromb Haemost (2004) 0.95

Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey. Ann R Coll Surg Engl (2010) 0.95

Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci (2005) 0.94

Gaps in the care of patients admitted to hospital with an exacerbation of chronic obstructive pulmonary disease. CMAJ (2004) 0.93

IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery. Clin Orthop Relat Res (2008) 0.92

Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients. Thrombosis (2012) 0.91

Thromboprophylaxis in surgical patients. Can J Surg (2003) 0.91

Foot pump prophylaxis for deep venous thrombosis-rate of effective usage following knee and hip arthroplasty. Int Orthop (2003) 0.90

Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J (2004) 0.90

Incidence of postthrombotic syndrome in patients undergoing primary total knee arthroplasty for osteoarthritis. Clin Orthop Relat Res (2009) 0.89

Incidence and risk factors for pulmonary embolism after primary musculoskeletal tumor surgery. Clin Orthop Relat Res (2013) 0.88

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. PLoS Med (2008) 0.88

Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg (2006) 0.87

The effect of abdominal support on functional outcomes in patients following major abdominal surgery: a randomized controlled trial. Physiother Can (2010) 0.86

Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care (2004) 0.86

Venous thromboembolic events in isolated severe traumatic brain injury. J Emerg Trauma Shock (2012) 0.86

Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations. Indian J Anaesth (2010) 0.85

Venous thromboembolism: A problem in the Indian/Asian population? Indian J Urol (2009) 0.85

Deep vein thrombosis prophylaxis in trauma patients. Thrombosis (2011) 0.85

The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty. Clinics (Sao Paulo) (2012) 0.85

Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford) (2008) 0.84

Continuous spinal anaesthesia versus ultrasound-guided combined psoas compartment-sciatic nerve block for hip replacement surgery in elderly high-risk patients: a prospective randomised study. BMC Anesthesiol (2014) 0.84

Anti-phospholipid antibodies in patients undergoing total joint replacement surgery. Thrombosis (2012) 0.84

Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer (2009) 0.84

Japanese 2011 nationwide survey on complications from spine surgery. J Orthop Sci (2014) 0.84

Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg (2009) 0.83

Hypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulation. Am J Surg (2013) 0.83

Use of antithrombotic medications among elderly ischemic stroke patients. Circ Cardiovasc Qual Outcomes (2010) 0.83

Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol (2010) 0.83

Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement. J Gen Intern Med (2002) 0.83

Low molecular weight heparin-induced skin necrosis-a systematic review. Langenbecks Arch Surg (2004) 0.83

Deep vein thrombosis following below knee immobilization: the need for chemoprophylaxis. Trauma Mon (2013) 0.82

Thrombo-prophylaxis in acutely ill medical and critically ill patients. Indian J Crit Care Med (2014) 0.81

Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA). BMJ Open (2013) 0.81

Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis. J Gen Intern Med (2016) 0.81

Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients. J Neurooncol (2009) 0.81

Overview of the perioperative management of lung volume reduction surgery patients. Proc Am Thorac Soc (2008) 0.81

Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients? Vasc Health Risk Manag (2009) 0.81

A multicenter review of deep venous thrombosis prophylaxis practice patterns for blunt hepatic trauma. J Trauma Manag Outcomes (2009) 0.80

The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests. J Clin Epidemiol (2005) 0.80

Venous thromboembolism prophylaxis. Clin Colon Rectal Surg (2013) 0.80

An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med (2009) 0.80

Imaging Findings of Liposuction with an Emphasis on Postsurgical Complications. Korean J Radiol (2015) 0.80

The use of reinfusion drains after total knee arthroplasty in patients treated with low molecular weight heparin for thromboembolic prophylaxis. HSS J (2005) 0.80

Venous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry. J Korean Med Sci (2015) 0.80

Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Ann Vasc Dis (2015) 0.80

Review of acute pulmonary embolism in a general hospital. Surg Today (2007) 0.80

Total mesorectal excision: what are we doing? Clin Colon Rectal Surg (2007) 0.79

Incidence of venous thromboembolic complications in instrumental spinal surgeries with preoperative chemoprophylaxis. J Korean Neurosurg Soc (2015) 0.79

Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79

Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan. Int Arch Otorhinolaryngol (2015) 0.79

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge. Thromb J (2011) 0.79

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials. Thromb J (2012) 0.79

Thrombo-prophylaxis in pelvic and acetabular trauma patients: a UK consensus? Int Orthop (2011) 0.79

IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics. BMC Musculoskelet Disord (2011) 0.78

Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement. BMC Musculoskelet Disord (2009) 0.78

Venous thrombosis after arthroscopic shoulder surgery: pacemaker leads as a possible cause: pacemaker leads as a possible cause. HSS J (2011) 0.78

Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery. ISRN Urol (2013) 0.78

Multiple ligament knee injury: complications. N Am J Sports Phys Ther (2008) 0.78

Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery. Eur J Health Econ (2007) 0.78

The Incidence of Deep Vein Thrombosis in Asian Patients With Chronic Obstructive Pulmonary Disease. Medicine (Baltimore) (2015) 0.78

Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop (2013) 0.78

Retrospective Evaluation of Anaesthesia Techniques for Hip Replacement Operations. Turk J Anaesthesiol Reanim (2014) 0.78

Impact of Introducing Anticoagulation-Related Prescribing Guidelines in a Hospital Setting using Academic Detailing. Ther Clin Risk Manag (2006) 0.78

Elastic stocking-induced foot necrosis in a patient with severe pneumonia. Ann Vasc Dis (2010) 0.78

Predicting perioperative venous thromboembolism in Japanese gynecological patients. PLoS One (2014) 0.77

Single-photon emission computed tomography in the screening for postoperative pulmonary embolism. Dig Dis Sci (2006) 0.77

Patient-reported history of leg ulceration 12-16 years after total primary knee or hip replacement. Acta Orthop (2011) 0.77

Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. World J Emerg Surg (2012) 0.77

Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing. J Cancer Res Clin Oncol (2004) 0.77

Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature. J Trauma Manag Outcomes (2010) 0.76

Management and prevention of venous thromboembolism including surgery and the pregnant state. Ochsner J (2002) 0.76

Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing. Bone Joint Res (2016) 0.76

Linking joint commission inpatient core measures and national patient safety goals with evidence. Proc (Bayl Univ Med Cent) (2009) 0.76

Perioperative morbidity and mortality associated with vitreoretinal and ocular oncologic surgery performed under general anesthesia. Trans Am Ophthalmol Soc (2003) 0.75

Venous thromboembolism deserves your attention. Crit Care (2001) 0.75

Thromboprophylaxis after replacement arthroplasty. Many surgeons prefer not to prescribe chemoprophylaxis after arthroplasty. BMJ (2001) 0.75

Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism. Ther Adv Hematol (2012) 0.75

Articles by these authors

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62

The effect of the orientation of the acetabular and femoral components on the range of motion of the hip at different head-neck ratios. J Bone Joint Surg Am (2000) 3.39

The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke (1999) 3.31

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet (1999) 3.30

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation (1996) 3.23

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med (1992) 3.23

Homotransplantation of the Canine Liver as an Orthotopic Vascularized Graft: Histologic and Functional Correlations During Residence in the New Host. Am J Pathol (1962) 3.14

Concern about safety of carotid angioplasty. Stroke (1996) 2.73

Prevention of venous thromboembolism. Chest (1995) 2.69

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37

Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart (2009) 2.28

Colorectal foreign bodies. Colorectal Dis (2005) 2.28

Prevention of venous thromboembolism. Chest (1998) 2.24

Cost-effectiveness of pulmonary embolism diagnosis. Arch Intern Med (1996) 2.24

Human chondrocyte apoptosis in response to mechanical injury. Osteoarthritis Cartilage (2001) 2.16

The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96

Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (1999) 1.91

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85

Prevention of venous thromboembolism. Chest (1992) 1.81

Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med (2000) 1.72

American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70

Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart (2006) 1.69

Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost (2012) 1.66

Physician practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg (1992) 1.63

The clinical course of distal deep venous thrombosis after total hip and total knee arthroplasty, as determined with duplex ultrasonography. J Bone Joint Surg Am (1994) 1.63

Extended indications for placement of an inferior vena cava filter. J Vasc Surg (1989) 1.62

Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes. Genome Res (1997) 1.60

Core decompression of the femoral head for osteonecrosis. J Bone Joint Surg Am (1986) 1.59

Steal syndrome complicating hemodialysis access. Cardiovasc Surg (1997) 1.54

Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med (1994) 1.54

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes. Heart (2010) 1.53

The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Arch Intern Med (1997) 1.53

Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med (1999) 1.50

Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.48

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart (2007) 1.47

Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood (2001) 1.46

Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med (1994) 1.44

Assessing risk associated with carotid endarterectomy. A statement for health professionals by an Ad Hoc Committee on Carotid Surgery Standards of the Stroke Council, American Heart Association. Circulation (1989) 1.41

Alterations in serum creatine kinase and lactate dehydrogenase. Association with abdominal aortic surgery, myocardial infarction and bowel necrosis. Chest (1990) 1.41

Asymptomatic carotid stenosis and unrelated operations: should we be more aggressive? J Am Coll Surg (2001) 1.40

Popliteal vascular entrapment. Its increasing interest. Arch Surg (1979) 1.36

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.34

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med (1997) 1.34

The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE. Heart (2010) 1.32

Dissociation of modular hip arthroplasty components after dislocation. A report of three cases at differing dissociation levels. Clin Orthop Relat Res (1992) 1.32

The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med (1973) 1.30

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet (1992) 1.29

Physician practices in the prevention of venous thromboembolism. Ann Intern Med (1991) 1.28

Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med (1992) 1.24

Accuracy of intramedullary versus extramedullary tibial alignment cutting systems in total knee arthroplasty. Clin Orthop Relat Res (1995) 1.24

Vascular injury related to lumbar disk surgery. J Trauma (1984) 1.24

Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery (1994) 1.22

Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med (1987) 1.20

Impact of mechanical trauma on matrix and cells. Clin Orthop Relat Res (2001) 1.19

Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.17

Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med (2000) 1.15

Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res (1998) 1.14

Intramuscular hemangioma. JAMA (1983) 1.14

The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc (2000) 1.13

Dilation of knitted Dacron aortic prostheses and anastomotic false aneurysms: etiologic considerations. Surgery (1983) 1.11

Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma (1995) 1.11

Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg (1997) 1.11

The efficacy of intramedullary femoral alignment in total knee replacement. Clin Orthop Relat Res (1995) 1.10

Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J (1973) 1.09

A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med (1994) 1.08

Tumors, mucus production, and hypercoagulability. Ann N Y Acad Sci (1974) 1.06

Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med (1998) 1.05

Quadriceps moment arm and quadriceps forces after total knee arthroplasty. Clin Orthop Relat Res (2001) 1.05

Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg (1998) 1.05

Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma. Br J Haematol (1970) 1.04

Limitations of pulsed-field gel electrophoresis for the routine surveillance of Campylobacter infections. J Infect Dis (2001) 1.04

Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med (1999) 1.03

Bilobed oblong porous coated acetabular components in revision total hip arthroplasty. Clin Orthop Relat Res (2000) 1.03

Prevention of chondrocyte apoptosis. J Bone Joint Surg Am (2001) 1.03

Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol (2001) 1.03

Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. N Engl J Med (1974) 1.02

Axillary artery compression and thrombosis in throwing athletes. J Vasc Surg (1990) 1.02

The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med (1992) 1.02

Acute pancreatitis after abdominal vascular surgery. J Am Coll Surg (2000) 1.02

Polyethylene contact stresses, articular congruity, and knee alignment. Clin Orthop Relat Res (2001) 1.02

Cartilage injury induces chondrocyte apoptosis. J Bone Joint Surg Am (2001) 1.02

Noninvasive detection of carotid stenosis following endarterectomy. Arch Surg (1981) 1.01

The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs. Br J Exp Pathol (1970) 1.01

Non-mechanical hemorrhage in severe liver injury. Ann Surg (1978) 1.01

Prediction of the development of sigmoid ischemia on the day of aortic operations. Indirect measurements of intramural pH in the colon. Arch Surg (1986) 1.01

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med (2001) 1.00

The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. Circulation (1975) 0.99

Recurrent hemarthrosis following a total knee arthroplasty. J Arthroplasty (1995) 0.99

Femoral anastomotic false aneurysms. An 11-year experience analyzed with a case control study. Ann Surg (1984) 0.98